Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial - Goldschmidt, Hartmut; Mai, Elias K.; Dürig, Jan; Scheid, Christoph; Weisel, Katja C.; Kunz, Christina; Bertsch, Uta; Hielscher, Thomas; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Hügle-Dörr, Barbara; et al. (Leukemia, 2020)
Gesehen am 09.09.2021